RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Acute pancreatitis in the use of canagliflozin: A rare side-effect of the novel therapy for type 2 diabetes mellitus.

Acute pancreatitis in the use of canagliflozin: A rare side-effect of the novel therapy for type 2 diabetes mellitus.

Add to Collection
2015 Jun Others Fist_Author_Year_PM

Full Author : ['Srivali, Narat', 'Thongprayoon, Charat', 'Cheungpasitporn, Wisit', 'Ungprasert, Patompong']
Journal Title : Journal of basic and clinical pharmacy
Chapter : Section18, Section4, Section8
Journal Year : 2015

Canagliflozin (Invokana) is an innovative treatment for type 2 diabetes mellitus (DM) approved in a new class acknowledged as sodium-glucose co-transporter 2 inhibitors. Acute pancreatitis is a very rare side effect with an incidence <1%. a 50-year-old wh.....

Keywords : ['type diabetes mellitus', 'rare sideeffect', 'novel therapy', 'acute pancreatitis', 'use', 'canagliflozin']